Compare CMCSA & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMCSA | BSX |
|---|---|---|
| Founded | 1963 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.9B | 103.6B |
| IPO Year | N/A | 2010 |
| Metric | CMCSA | BSX |
|---|---|---|
| Price | $28.06 | $62.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 21 |
| Target Price | $35.01 | ★ $104.48 |
| AVG Volume (30 Days) | ★ 23.3M | 13.1M |
| Earning Date | 04-23-2026 | 04-22-2026 |
| Dividend Yield | ★ 4.60% | N/A |
| EPS Growth | N/A | ★ 55.20 |
| EPS | N/A | ★ 1.94 |
| Revenue | N/A | ★ $9,076,000,000.00 |
| Revenue This Year | $1.78 | $12.02 |
| Revenue Next Year | N/A | $10.41 |
| P/E Ratio | ★ $5.86 | $32.24 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $25.75 | $61.25 |
| 52 Week High | $36.66 | $109.50 |
| Indicator | CMCSA | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 33.40 | 24.41 |
| Support Level | $27.41 | N/A |
| Resistance Level | $28.18 | $76.77 |
| Average True Range (ATR) | 0.73 | 1.90 |
| MACD | -0.14 | -0.37 |
| Stochastic Oscillator | 6.43 | 7.01 |
Comcast is made up of three parts. The core cable business owns networks capable of providing television, internet access, and phone services to 65 million US homes and businesses, or nearly half of the country. The firm provides services to about half of the locations in this territory. Comcast acquired NBCUniversal from General Electric in 2011. NBCU owns several cable networks, including CNBC, MSNBC, and USA, the NBC network, the Peacock streaming platform, several local NBC affiliates, Universal Studios, and several theme parks. The firm plans to spin off most of its cable networks. Finally, Sky, acquired in 2018, is a large television provider in the UK and Italy.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.